Mr. Chua helms the SHAPE Group at IHiS covering Strategy, HITMAP, Alliance, Planning and Exploration. He shapes the Singapore Healthcare ecosystem through focused strategy, driving the Health IT Masterplan (HITMAP) to guide MOH on the IT portfolio investment, forming alliance with industry to drive innovation and leading the planning effort on selected strategic initiatives to support Singapore’s Health Care vision of ‘Better Health, Better Care and Better Life’. Mr. Chua also oversees and manages engagement with ministries, research institutions and industry partners, both locally and globally, to facilitate opportunities for collaboration and explore emerging technologies for the healthcare ecosystem.

Prior to his current appointment, Mr. Chua was a Managing Director for a global IT consulting firm, Accenture. He also held several leadership positions in various industries, dealing with clients in the Asia Pacific region. He has led many large-scale IT consulting and implementation projects, assisting government agencies and regional Multi-National Corporations (MNCs) on their IT Strategy and in streamlining their IT systems.

Mr. Masagos entered politics in 2006, after being elected as Member of Parliament for Tampines Group Representation Constituency, and was appointed Senior Parliamentary Secretary for the Ministry of Education. Prior to that, Mr. Masagos was working in Singapore Telecommunications Limited and last held the position of CEO, SingTel Global Offices. From 2008 to 2014, Mr. Masagos held other positions in the Singapore Government, within the Ministries of Foreign Affairs and Home Affairs. He was appointed Minister-in-Charge of Muslim Affairs in May 2018. From October 2015 to July 2020, Mr. Masagos was Minister for the Environment and Water Resources. He took on his current appointment on 27 July 2020.

Mr. Bruce Liang is the Chief Executive Officer (CEO) of Integrated Health Information Systems (IHiS) Pte Ltd. Mr Liang also held concurrent appointments as the Chief Information Officer of the Ministry of Health Singapore (MOH) from Feb 2013 to Sep 2020, and the Chief Information Officer of MOH Holdings from Feb 2013 to Oct 2016. Bruce helps to advance Singapore’s healthcare IT to support better population health and health administration. Prior to joining MOH and IHiS, Bruce was with Accenture for 19 years. He held various leadership roles, including Managing Director of ASEAN Products Practice as well as the Health and Public Sector Practice in Asia Emerging Markets. He has extensive experience in complex and large scale enterprise planning and Business-IT transformation programs for Governments and large businesses across Asia.

Bruce graduated from the National University of Singapore (NUS) Department of Information Systems and Computer Science (DISCS). He serves and advises on the Executive Committee of Singapore Computer Society (SCS), IMDA’s Governing Council of TechSkills Accelerator (TeSA), NUS School of Computing Industry Advisory Committee (IAC), Advisory Board of the NTU Ageing Research Institute for Society and Education (ARISE) and LccL Coding Academy. He is currently also serving on the Boards of Assurity Trusted Solutions Pte Ltd, SelfDrvn and IHiS. He was formerly a board member of the Government Technology Agency of Singapore (GovTech) and Accounting and Corporate Regulatory Authority (ACRA).

Dr. John Halamka is an emergency medicine physician, medical informatics expert and president of the Mayo Clinic Platform, which is focused on transforming health care by leveraging artificial intelligence, connected health care devices and a network of partners.

In his role at Mayo Clinic, Dr. Halamka oversees the future direction of the Mayo Clinic Platform that will help establish Mayo Clinic as a global leader in digital healthcare. Dr. Halamka has been developing and implementing health care information strategy and policy for more than 25 years.

Prior to his appointment at Mayo Clinic, he was the Executive Director of the Health Technology Exploration Center for Beth Israel Lahey Health, Chief Information Officer at Beth Israel Deaconess Medical Center, and International Healthcare Innovation Professor at Harvard Medical School.

Dr. Halamka completed his undergraduate studies at Stanford University, earning his medical degree at the University of California, San Francisco, and pursued graduate work in bioengineering at the University of California, Berkeley. He completed his residency at UCLA-Harbour Medical Center in the Department of Emergency Medicine. He is a member of the National Academy of Medicine.

Mr. Chan Yeng Kit was appointed Permanent Secretary (Health) in December 2019. Prior to this, he was Permanent Secretary (Defence) from 2013 to 2019, Permanent Secretary (Defence Development) from 2012 to 2013, and Permanent Secretary (Information, Communications & the Arts) from 2008 to 2012.

Mr. Chan’s career has spanned a range of appointments in Government, the labour movement, and the private sector. These include management positions in the Public Service Division, National Trades Union Congress, Singapore-Suzhou Township Development Pte Ltd, Ministry of Trade & Industry, Ministry of Defence, and Ministry of Education. He was Chief Executive Officer of the Infocomm Development Authority of Singapore from 2005 to 2007.

Mr. Chan graduated with First Class Honours in Mathematics from the University of Tasmania, earned his Master in Public Administration from Harvard University, and completed the Advanced Management Programme at the Wharton School of the University of Pennsylvania. He was awarded the Singapore Armed Forces National Serviceman of the Year Award in 1999, conferred the Public Administration Medal (Silver) in 2000, and the Public Administration Medal (Gold) in 2010.

Professor Tan Chorh Chuan was appointed as the inaugural Chief Health Scientist and concurrently, Executive Director of the new Office for Healthcare Transformation in Singapore’s Ministry of Health since 1 January 2018. He is also the Chairman of the Human Health and Potential Executive Committee which oversees Singapore's health and biomedical sciences research initiative.

Prof. Tan was President of the National University of Singapore from 2008 to 2017, and Provost of NUS from 2004-2008. He has served in senior leadership roles in the healthcare and biomedical sciences sectors including as Chairman of the National University Health System from 2011-18, Deputy Chairman of the Agency for Science Technology and Research (ASTAR) from 2004 to 2018 and Dean of the NUS School of Medicine from 1997-2000.

He was Director of Medical Services in the Ministry of Health from 2000-2004, in which capacity he led the public health response to the 2003 SARS epidemic. He is a member of the Boards and Advisory Boards of several international organisations. A renal physician-scientist, Prof Tan obtained his medical training at NUS, and research training at the Institute of Molecular Medicine, University of Oxford. He is the first Singaporean to be elected as an international member of the US National Academy of Medicine

Ms. Ngiam Siew Ying joined the Public Service in 1999. She is currently the Deputy Secretary (Policy) in the Ministry of Health. In this role, she oversees areas in the Ministry concerning systems planning, financing and corporate policies. From 1 Jan 2022, Ms. Ngiam will take up the role of Chief Executive of the Integrated Health Information Systems (IHiS).

Ms. Ngiam was previously Senior Director of the National Population and Talent Division (part of the Strategy Group in the Prime Minister’s Office) where she oversaw policy issues related to population and demography. Prior to that, she was with the Ministry of Transport, where she was Deputy Director of Sea Transport and later Director of Land Transport. She has also held past appointments at the Ministry of Defence, and the Defence Science and Technology Agency.

Dr. Tham Tat Yean is CEO and co-founder of Frontier Healthcare Group. He is also a practising Family Physician. He currently serves as Fellow in the MOH Office of Healthcare Transformation and as Senior Consultant with the MOH Primary and Community Care Division (both part-time appointments). He chairs the Primary Care Network Council and co-chairs the National GP Advisory Panel.

Dr. Tan is also serving in several other Ministry of Health and public healthcare institution committees. He is an Associate Programme Director in the NUHS Family Medicine Residency Programme and a Visiting Family Physician to the NUHS Department of Family Medicine. He has previously served in the Councils of the College of Family Physicians Singapore and the Singapore Medical Association and was a Board Member of Agency of Integrated Care from 2009 to 2012.

Dr. Tham's current area of interest is in the development of collaborative models of primary care with various community entities and public healthcare institutions, with a vision of transforming primary care to meet the healthcare challenges of an ageing population.

Mr. Ong Leong Seng is the Chief Technology Officer at Singapore’s Ministry of Health, with a concurrent appointment as Director, National Chief Architect Office. As the HealthTech leader for the ministry, he plays a critical role in developing the Ministry’s technology vision, strategic direction and future growth in technology to strengthen the healthcare sector’s capabilities. He is also actively involved in the formulation of the national digital health masterplan, setting sector-wide IT standards and guidelines to drive sector guidance and governance. Through the architect office, he provides leadership in the establishment and alignment to National Architecture and Standards.

Prior to his current appointment, Mr. Ong helmed the Delivery Group at Integrated Health Information Systems, and oversaw the architecture and solution governance, programme and project implementation, infrastructure services and support. He was responsible for the day-to-day operations of over 700 IHiS-managed systems for Singapore’s public healthcare sector.

He has more than 20 years of experience in the design, development, implementation and operations of large-scale enterprise-wide IT systems. These include mission-critical clinical systems, cloud-services, broadband networking, e-commerce and logistic tracking systems.

Mr. Ong was a National Computer Board scholar who graduated from the University of Illinois at Urbana-Champaign with a Master of Science (Computer Science), Bachelor of Science (Computer Engineering) and International Minor in Japanese. Mr. Ong is a certified TOGAF (The Open Group Architecture Framework), PMP (Project Management Professional) and CITBCM (Certification in IT Business Continuity Management) professional.

Mr. Robert DeMichiei is the retired Executive Vice President and Chief Financial Officer of University of Pittsburgh Medical Center (UPMC), a $24B+ nonprofit health system and leading health care provider and insurer. During his time at UPMC, Rob implemented best practices in controllership, with UPMC achieving voluntary SOX 404 certification in 2006. He also led UPMC’s activity-based costing/service-line implementation and consumerism initiatives. In addition to Finance, Rob led the Supply Chain Management and Revenue Cycle functions, driving integration, technology infusion and process improvement/efficiency throughout the organisation. Rob’s teams created a number of healthcare technology solutions, three of which were commercialised and spun-off.

Before his 16- year tenure at UPMC, Rob held various executive roles with the General Electric Company (GE) and Price Waterhouse in Pittsburgh. Rob currently serves as a Board Director for Waystar, where he is the Audit, Compliance and ESG Committee Chair, AAA East Central and Auto Club Enterprises. Rob also serves as a Strategic Advisor for Health Catalyst (NASDAQ; HCAT).

Rob has a BA in Business Economics from the University of Pittsburgh.

Ms. Holly Rimmasch serves as the Chief Clinical Officer and SVP & GM, Clinical Quality Business Unit at Health Catalyst. She bridges the gap between technology, data, analytics and the clinical world to ensure that Health Catalyst’s products and services are being developed and delivered in a way that enables healthcare organisations to take full advantage and effect meaningful improvements and sustainable change. Holly oversees clinical improvement, patient safety, quality, and population health and she currently leads the company-wide COVID-19 Task Force.

Holly has an extensive healthcare and operational experience. Prior to joining Health Catalyst, she helmed the role of Assistant VP at Intermountain Healthcare responsible for Clinical Services and the system Clinical Operations Director for Cardiovascular and Intensive Medicine. Holly’s leadership roles at Intermountain and Health Catalyst enables her to affect change at a system level. Holly also co-founded and was a Principal in HMS, Inc, a healthcare strategic consulting firm focusing on population health.

Holly’s rise to leadership positions stems from hard work and a passion for improving healthcare. Early in her career, she recognised that integrating technology, data, and analytics with best practices and adoption principles was critical to achieve and sustain improvement. Her mission has always been unwavering: to create a patient centered higher-quality, lower-cost, sustainable health system.

Holly holds a Master of Science in Adult Physiology from the University of Utah and a Bachelor of Science in Nursing from Brigham Young University.

Mr. Nawal Roy is Founder and CEO of Holmusk, bringing more than fifteen years of finance and strategy consulting experience to the helm of the company. After seeing first-hand the transformation of the finance sector driven by data and technology, Nawal decided to focus on helping transform healthcare in the same way. There is an urgent need for more behavioral health evidence and this need is what spurred Nawal to start Holmusk. Nawal carves out the strategic direction of Holmusk, leading from the front with round-the-clock hustle and infectious energy.

Prior to this, Nawal was Co-Founder and CEO of HelloPay (Rocket Internet venture), and a Junior Partner at McKinsey & Company. He has served as a World Economic Value-Based Healthcare Steering Committee and co-founded Galen Growth Asia - The Asia Health Tech Connector. Having enjoyed a global career spanning from New York to Tokyo, his close involvement with markets across North America, Europe, Southeast Asia, India, and China yields uniquely diverse experience in building next generation global companies.

Dr. David Levine, MD MPH MA, is a practicing general internist and clinician-investigator at Brigham Health and Harvard Medical School. He is active in clinical and translational research through a focus on optimising quality time at home by shifting care home, decentralising care, digital health technology, and measuring the quality and experience of health care.

As a medical director for strategy and innovation for the Brigham Health Home Hospital and co-chair of the Hospital at Home Users Group, David sees his role as helping patients achieve the right care at the right time in the right place by designing, implementing, and evaluating innovative interaction spaces among a care team, technology, caregiver, and a patient.

David received his undergraduate degree from Pomona College in biology and politics. He earned his master’s in teaching in special and secondary science education and served as a high school chemistry teacher and science department chair in Chicago Public Schools. He received his medical degree from Washington University in St Louis and completed his residency at New York University and Bellevue Hospital in internal medicine - primary care. He completed a general internal medicine fellowship at Brigham Health and Harvard Medical School and received his master’s in public health at the Harvard School of Public Health.

Mr. Jeffrey Lu is passionate about building companies using technology and science for impact. He has fifteen years of business, executive management, and entrepreneurial experience, creating sustainable businesses, shareholder value and liquidity events.

Jeff co-founded Engine Biosciences (“Engine”) and has served as its CEO since inception. Engine integrates machine learning, high-throughput biological experimentation, and innovative chemistry to decipher biology and develop new medicines for patients. Jeff has led Engine in raising over US$53 million in Seed and Series A funding from leading US and Asian venture capital and private equity firms.

In addition to Engine, Jeff has played founding and leadership roles in several biotechnology and technology companies. This includes Enleofen Bio (developing therapeutics targeting IL-11 for fibrosis; preclinical pipeline acquired by Boehringer Ingelheim for >$1 billion), PairX Bio (venture-backed cancer immunotherapy company), and AAE (travel technology company built to >$100 million revenue and profitability within three years of inception; acquired by Expedia Inc in transactions valuing AAE at ~$300 million), among others.

Jeff began his career as a management consultant at Bain & Company. Subsequently he joined AirAsia as Head of Strategy and Group Head of Commercial Strategy, leading teams covering strategy, commercial strategy, data analytics, and digital marketing. He played a principal role in establishing several new joint ventures and businesses for the group.

Jeff has been named a Young Global Leader by the World Economic Forum. He received his BA summa cum laude from University of Pennsylvania.

Dr. Steven Tucker is a Health Futurist and Preventive Oncologist. He is the Founder of Tucker Medical, a Singapore-based multi-specialty practice that combines both primary care and sub-specialty medicine in Singapore and to patients across South East Asia. Tucker Medical’s mission is to provide team-based comprehensive care and prevention to patients and their families across the continuum of health and disease.

Dr. Tucker has extensive experience in digital and population health. He was Chief Medical Officer at CXA Group and previously held consulting and strategic roles at MetLife Asia, the Lumen Lab Innovation Centre, and was the founding Global Health Advisor at Singtel. He is a Senior Health Advisor at Beyond Limits AI and a faculty member at the Singapore-MIT Alliance for Research and Technology (SMART) teaching medical innovation, design thinking, and entrepreneurship. Outside of clinical practice, Dr. Tucker is a professional speaker, strategist, and consultant advising start-ups, venture funds, multinationals, and governments on integrating new technologies in health and medicine.

Dr. Tucker trained in Internal Medicine, Haematology, Oncology, and Stem Cell Transplantation at the UCLA Center for Health Sciences. While at UCLA, he studied molecular biology and joined the UCLA faculty as Assistant Professor of Clinical Medicine in 1999. Dr. Tucker is a Fellow of both the Singapore Academy of Medicine and the American College of Physicians. He has received numerous honours, including an ASCO Merit Award, an NIH Commendation, the UCLA ‘STAR’ Program Award, and a Pew Foundation Fellowship.

Ms. Mallory Heinzeroth is the Asia Pacific Regional Executive for Epic, a healthcare software company keeping patients at the heart of their design and community engagement to help future generations be healthier.

Originally from the United States and based in Australia now, Mallory has focused her career on healthcare around the world. Starting with the Jensen Medal and building a program for women and children’s health in rural Nicaraguan communities, to leading top healthcare organisations such as Mayo Clinic through a transformational EHR implementation providing better safety, efficiency, and healthcare outcomes, Mallory is dedicated to healthcare technology improving lives across the globe.

Mallory is the Implementation Executive for the Next Generation EMR implementation of Epic at National University Health System (NUHS) and National Healthcare Group (NHG) in Singapore.

Ms. Ng Li Lian is the co-founder and Managing Director of Tetsuyu Healthcare, Singapore. She is responsible for strategic and corporate development, marketing and operations.

Prior to founding Tetsuyu, Li Lian has close to two decades of experience in consumer banking where she drove strategy, marketing and business management. As Head of the Personal Banking segment at OCBC Bank, she was responsible for the customer value propositions of the clients in the consumer bank.

Li Lian is passionate about developing and implementing strategies that solve the pain points of consumers and sees great possibilities to transform services for the ageing population in Singapore. She also sees an excellent opportunity for public, private and community sector partnerships to address some of the issues relating to Singapore’s ageing society.

Li Lian and her team at Tetsuyu are pushing the boundaries on eldercare technologies with care management, AI wound management and other applications. The team was honoured with the HIMSS Asia Pacific Excellence in Start-up Innovation Award 2017, Innovation of the Year –Technology award at the 8th Eldercare Innovation Award 2020 and Grand Prize Winner for 2021 Healthy Aging Prize for Asian Innovation (HAPI).

Li Lian holds a Bachelor of Accountancy from the National University of Singapore, a Bachelor of Law (Hons) from the University of London, an Advance Diploma in Wealth Management from the Wealth Management Institute and an Executive MBA from INSEAD.

Dr. Shinsuke Muto is the co-founder and Director of Tetsuyu Healthcare, Singapore. He brings into Singapore, Japan’s holistic home care concept and his deep experience of pairing a good care model with technology to improve nursing and medical care, and productivity.

A Cardiologist by training, Dr. Muto’s passion is to help the elderly live happily with dignity and quality. He was driven to create a home care model enabled by cloud technology after witnessing elderly patients’ suffering post hospital discharge. His four clinics in Tokyo and Miyagi serve 1,000 elderly patients with 24,000 home visits annually in Japan, including Tsunami-swept communities.

Dr. Muto advises the Japanese government on healthcare information technology and was awarded Innovator of the Year 2015 by a consortium recognising the most innovative healthcare professional in Japan. He was awarded the 29th Takemi Incentive Award in 2019.

Currently, Dr. Muto also serves as a clinical professor at the Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences, as Board Member at Health and Global Policy Institute, as Director at Asia Pacific Initiative, and as Chairman of the Medical Excellence JAPAN Inbound Committee. Previously, Dr. Muto was Court Physician, Imperial Household Agency of Japan, and a Consultant with McKinsey and Company in Japan.

Dr. Muto holds an Executive MBA from INSEAD and a Master of Public Health from Johns Hopkins University.

Ms. Rosaline Chow Koo invested $5M of her savings and borrowed another $5M to build her startup CXA after 5 years trying to convince her firm to invest in Asia. CXA is the first private workplace wellness exchange in Asia, pioneering the flex wellness market place which allows firms to bundle their healthcare budget with benefits and wellness for their employees. CXA won Insurtech of the Year and Rosaline won Woman Leader of the Year from the Asia Insurance Industry Awards.

Rosaline supervised Procter & Gamble factory lines in Iowa and then worked on Wall Street. She launched two dot-com start-ups before moving to insurance. Rosaline also led Mercer and Marsh Benefit, the latest employee benefits brokerage and HR benefits consultancy in Asia Pacific, overseeing a 14-county operation and growing the business by 800% over 8 years. She graduated from UCLA Cybernetics and Columbia Business School.

Mr. Thomas Hummel heads Strategy and Innovation for Digital Health at Siemens Healthineers in Erlangen, Germany. In his role, he oversees the development of the digital strategy, portfolio management for digital health assets and leads the global customer collaborations program.

Prior to joining Siemens Healthineers, Thomas was head of Digital for the Healthcare business unit for Merck KGaA in Nyon, Switzerland, where he also led the healthcare insights team which provided data analytics services across the healthcare business. Before that, he oversaw IT strategy for Siemens Healthcare.

Thomas started his professional career at Accenture as a technology consultant in the Sophia Antipolis Technology Park in France, where he delivered technology solutions to various industries.

Mr. Lim Wai Mun is the Founder and Chief Executive Officer of Doctor Anywhere, with more than 10 years of experience in the investment and start-up space.

Launched in 2017, Doctor Anywhere is a regional tech-led healthcare company that harnesses the power of technology and connectivity, to combine a holistic range of health and wellness services into a single, integrated platform.

Doctor Anywhere’s mission is to bridge efficiency gaps in the health and wellness ecosystem, to bring a seamless and convenient healthcare experience to millions in the region.

Before Doctor Anywhere, Wai Mun spent three years in private equity, before devoting close to a decade to Temasek Holdings. He was instrumental in the conceptualisation and establishment of Pavilion Energy, a Singapore-based LNG company with significant stakes in the global energy market, equipping him with the essential insights and acumen to lead a team through the complexities of the healthcare landscape.

Born and raised in Singapore, Wai Mun graduated with a Bachelor of Mechanical Engineering at National University of Singapore.

Value-based healthcare focuses on quality of care rather than quantity, and examines from the perspective of the entire patient journey –from diagnosis and treatment to after-care and possibly prevention. Over the years, there have been many models developed with mixed success.

Learn from industry veteran and keynote speaker, Ms. Holly Rimmasch, on value-based care pitfalls and critical success factors to achieve population health goals at #IHiSHealthTechX.

1. Find out more about different population health models
2. Gain fresh perspectives into how data, analytics and technology can be used for value-based care
3. Learn more about establishing benchmarks for successful population health management

Behavioural health is a defining problem of our generation, made worse by the COVID-19 pandemic. Behavioural health affects one’s wellbeing, emotions and biology that eventually leads to chronic diseases. Current key challenges in delivering behavioural healthcare in Singapore include social stigma, lack of quantitative biomarkers to diagnose the disease and silos between mental health and other healthcare disciplines that impede continuum of care for behavioural health.

Mr. Nawal Roy shares how Holmusk pioneered a novel approach to generate Real-World Evidence for behavioural health to accelerate drug development, developing AI-powered analytics tools and digital solutions to address behavioural health innovation and research practices at #IHiSHealthTechX.

1. Hear ideas on strategies to apply analytics on behavioural health data to deliver evidence-based insights for pharmaceutical companies and healthcare providers
2. Extract lessons learnt from partnerships with key stakeholders in the healthcare ecosystem in Singapore in the quest to achieve care transformation in behavioural health

While the concept of a home-hospital is still new in Singapore, it is well established in the US. Dr. David Levine conducted numerous randomised control trials at Brigham and Harvard and collected evidence that show a reduction in patient readmission, better recovery with lower costs incurred by healthcare providers with this novel care model that brings acute hospital services to patients at home.

Will this model work in the Singapore society that has a strong cultural belief that the hospital is the place of treatment and access to acute hospitals are accessible within minutes away? Current Singapore healthcare subsidies that favor inpatient care instead of community-based care may also impede patients from adopting the home-hospital concept.

1. Learn from the US home-hospital experiences
2. Understand the key technologies to enable successful of home-hospital adoption
3. Establish strategies to increase patients, caregivers and healthcare providers’ confidence on this new care model
4. Glean into the future trends of home-hospital

Precision medicines for patients with certain genetic mutations have demonstrated the ability to transform patients’ lives, and new technology platforms have emerged to translate data into actionable insights and products.

As a data-rich nation, Singapore is well positioned to be a global leader in organising large datasets on genomic, phenotypic, lifestyle and clinical to grow an innovation ecosystem on precision medicine. At #IHiSHealthTechX, Mr. Jeffrey Lu shares how Engine Biosciences integrates machine learning, high-throughput biological experimentation, and innovative chemistry to decipher biology and develop new medicines for patients. In order to achieve this, he will share the importance to have 3Vs (volume, variety, velocity), good quality and easily accessible human datasets to achieve full positive potential of precision medicines.

1. Explore the latest machine learning developments in precision medicines
2. The data requirements and the right data policies to ease precision medicine companies to maximise the possibilities of precision medicines

Current research has shown: (1) many common types of cancer have strong roots in diet and lifestyle, (2) obesity may overtake tobacco as the number one cause of preventable cancers and (3) cancer survivors are equally prone to other chronic conditions such as diabetes, hypertension and heart disease.

Additionally, the paradox of population health is that it’s all about the individual. To improve our collective health, we must focus on personalised support for the most significant impact. Hear from Dr Steven Tucker at #IHiSHealthTechX on how his team delivers personalised primary care to his patients through an integrated and novel care approach that goes beyond typical specialist service.

1. Gain insights into personalised health support and programs provided through team-based care from specialists, primary care physicians, and nurses as well as dieticians, mental health, and fitness professionals
2. Understand physician’s adaption to digital-first thinking, wearable technologies, precision medicine, and telehealth for medical care

A population-based approach to healthcare has proven benefits in care equity, quality of individualised care, and value care spending. By leveraging technologies and interoperable platforms, we can create a connected healthcare ecosystem to drive positive health outcomes and deliver a seamless healthcare experience for patients, thereby contributing towards successes in population health strategies.

At #IHiSHealthTechX, Ms. Mallory Heinzeroth shares how organisations leverage EMR platforms to better understand their populations' needs, empower patients to be active participants in their own care, create a connected healthcare ecosystem, and drive measurable clinical and financial improvements.

1. Hear how various healthcare providers are using Epic to succeed in their population health and value care initiatives
2. Learn about the interoperable platforms available to Epic and non-Epic providers to create a seamless healthcare experience for your patients
3. Hear ideas for how this ecosystem can enable you to improve patient care across the country

Japan is lauded for its successes in aged care, especially on shifting care from acute to community settings, particularly home care. The success stems from major overhaul in Policy, Funding, Ecosystem, Public Education and Technology.

Among these factors, technology remains a relatively weak link due to poor adoption by care providers, digital fragmentation and the lack of integrated information sharing model. The COVID pandemic has cast the spotlight on the future of community care as it becomes even more necessary than before to transform.

Dr. Shinsuke Muto and Ms. Ng Li Lian discusses how Japan mitigates the digital challenges and the lessons to learn from Japan in caring for our elders in the community at #IHiSHealthTechX.

1. Deep dive into Japan’s key success factors in community care
2. Learn about Japan’s telehealth deployments and case studies of patient driven digital care models
3. Glean into the future of aged care with technology

Population health is a collective effort of public, private and the people sectors. Corporates play critical roles to care for the wellbeing of their employees and provide the right level of health protection coverage for them and their family members. As most people spend majority of their time working, companies can partner healthcare providers to nudge employees to adopt healthy lifestyles by putting the right incentives in place.

Hear from Ms. Rosaline Chow Koo at #IHiSHealthTechX on how CXA builds a technology platform to connect companies and employees to insurance, clinics, hospitals, labs and wellness providers.

1. Explore different partnership model between companies, employees, insurance and healthcare service providers
2. Discover ways to empower employees to make informed decisions on lifestyle choices, preventive health and treatment options through digital platform
3. Learn how to leverage data to recommend and reward for health improvements to reinforce healthy habits.

The growing cost of serving an ageing and increasing chronic disease population is forcing healthcare to digitise quickly. This is happening around the globe, including Europe. Even though the COVID pandemic has accelerated the digital transformation, a diverse set of obstacles, such as economical, legal, ethical and regulatory, have slowed the adoption of digital solutions and hindered the realisation of the expected benefits.

At #IHiSHealthTechX, hear from Mr. Thomas Hummel on Europe’s healthcare digitalisation journey.

1. Gain insights on Europe’s healthcare digitalisation journey
2. Examine the case studies on digital health adoption barriers such as economical, legal, ethical and regulatory
3. Extract key learnings that are applicable to Singapore

The Covid-19 pandemic accelerated the adoption of telehealth – by an estimate of 5 years. The technology offers improved access to medical care, patient engagement and greater convenience in a time of lockdowns, social distancing and stay-at-home orders. While Singapore population is digitally savvy - with 9 in 10 adults using a smartphone and most households are well connected to the internet - there are challenges faced by telehealth adoption, such as changing ingrained user behaviours and concerns surrounding the lack of physical examination. Join Mr Lim Wai Mun, founder and CEO of Doctor Anywhere, as he shares his mission to transform the regional healthcare landscape through technology and innovation. Against the backdrop of a global public health crisis, Doctor Anywhere has expanded their operations to 5 countries in Southeast Asia, to achieve a ~400% growth in the past year. The platform now serves over 1.5 million users in the region.

1. Learnings from the founder on his 5-year journey in growing a regional telehealth platform
2. Identify the critical success factors and opportunities that contributed to Doctor Anywhere’s rapid growth and wide user adoption

Mayo Clinic is one of the largest not-for-profit academic health systems in the US. It has been recognised as the best hospital in the nation for 2021-2022 by the US News and World Report.

Join Dr. John Halamka, Keynote speaker for #IHiSHealthTechX as he shares about the Mayo Clinic Platform’s approach to improve population health. From gathering varieties of health-related data, building new algorithms, validating that the algorithms are fit for purpose, and delivering knowledge in enhanced workflows, learn Mayo Clinic’s approach to ensure that patients receive the right care in the right place at the right time.

1. Learn about Mayo Clinic Platform’s business model and how it helps improve population health
2. Unlock insights from Mayo’s experience in applying data collected to create value, such as segmented approach to nudge behaviour change, predicting potential diseases in a population and aiding policy makers to design healthcare policies
3. Understand the challenges and lessons learnt from deploying innovative health technologies in clinical workflow, and how the patients’ privacy and ethnics concerns are addressed
4. Derive the right success metrics for innovations to improve population health

How can we go upstream to improve population health, redesign preventive health strategies, as well as nudge behaviours for our citizens to adopt healthier lifestyles and habits to achieve better health? How can we achieve care transformation and overcome the obstacles for a more integrated and patient-centric care? Why is population health important and why now?

Join in Let’s C.H.A.T. to hear our esteemed panelists as they dissect the issues surrounding the future of population health, the possibilities, potential road blocks and vision for 2030 at #IHiSHealthTechX.

Hear from the panelists’ multiple perspectives- the administrator, clinicians and technologists, with Mr. Chan Yeng Kit, Permanent Secretary (Health); Mr. Tan Chorh Chuan, Chief Health Scientist, MOH,; Ms. Ngiam Siew Ying, Deputy Secretary (Policy), MOH and IHiS CEO-Designate; Mr. Tham Tat Yean, CEO and Family Physician Frontier Medical Group, Fellow, MOHT, Senior Consultant, MOH Primary & Community Care Division

1. Learn about Singapore’s impetus for a National Population Health strategy
2. Deep dive into the importance of adopting a multi-pronged approach to develop a healthcare system capable of delivering effective personalised care
3. Understand the challenges and longer term structural and system shifts required to achieve our goals

Cost sustainability is important when delivering good health outcomes and positive patient experience to a population. Health systems need to have full line-of-sight into their clinical and service-line costs to make strategic financial decisions.

Hear from Mr. Robert DeMichiei, a CFO’s perspective on how activity-based costing is applied in the healthcare system to improve clinical care delivery at lower healthcare costs and achieve population health goals. Get insights into better accountability for IT investments and manage your IT spend to ensure operating alignment, ROI realisation and ongoing innovations at #IHiSHealthTechX.

1. Discover the differences between activity-based costing, traditional relannetive value units (RVUs) costing, and ratio of costs-to-charges (RCC) costing
2. Learn the application of activity-based costing to create new “pools” of cost for optimisation and reduction using advance analytics
3. Quantify the financial impacts of population health management that guide the payment system for population health